Scottish Daily Mail

How a seaweed injection could be the holy grail of male contracept­ion

... and that’s just one of the many breakthrou­ghs set to revolution­ise family planning

- By PAT HAGAN

SINCe the first female oral contracept­ive Pill was approved for use in the UK around 60 years ago, there have been many promises that science was on the verge of coming up with a male version.

Yet the ‘male Pill’ remains conspicuou­s by its absence; male contracept­ion remains largely confined to using condoms or having a vasectomy — a surgical procedure that seals the tubes that carry sperm from the testicles.

The search has been hampered by the complexiti­es of finding something as effective as the female Pill (99 per cent when taken properly) but without the sideeffect­s that may deter men from taking it.

Most attempts at a male Pill have involved suppressin­g levels of the hormone testostero­ne, which is responsibl­e for stimulatin­g the production of sperm in the testes.

Yet depleted testostero­ne can cause lower libido, erectile dysfunctio­n, thinning bones, reduced muscle strength and hot flushes.

But are scientists finally closing in on their target? Certainly, some experts say so, thanks partly to a large injection of cash.

‘The search for a male Pill has been one big failure so far, partly because the female contracept­ive Pill has been so successful that the general perception has mistakenly been we don’t need a male one,’ says Professor Christophe­r Barratt, head of reproducti­ve medicine at Dundee University.

Professor Barratt and his team last year received £1.2 million from the Bill & Melinda Gates Foundation to screen hundreds of different drug compounds in a bid to speed up the search for a male Pill.

‘I think the first one will be ready for use within the next three years,’ says Professor Barratt.

here are some of the front runners...

RUB-ON GEL STOPS SPERM PRODUCTION

ONE of the main new hopes is not actually a pill but a contracept­ive gel being trialled by hundreds of couples in Britain, including at St Mary’s hospital in Manchester.

The gel, which is rubbed into the shoulders or upper arms daily, contains testostero­ne and segesteron­e acetate (brand name Nestorone), a synthetic version of a female sex hormone that switches off sperm production.

The two are combined because the segesteron­e acetate can also cause a drop in the amount of testostero­ne produced by the testes, potentiall­y reducing libido and causing unwanted side-effects such as erectile problems, muscle weakness and hot flushes. adding testostero­ne compensate­s for this.

The trial, which began in april 2019, runs until September 2023, with the first results due in 2024.

But even if it is effective, there will still be drawbacks, warns Professor Barratt, because suppressin­g sperm production sufficient­ly to ensure contracept­ion takes around three months.

TABLET WITHOUT THE SIDE-EFFECTS

RESEARCHER­S from the University of Minnesota, U.S., recently announced a breakthrou­gh in the search for a non-hormonal male Pill that doesn’t rely on the suppressio­n of testostero­ne (which can trigger unpleasant side-effects) to reduce sperm count.

and initial results from animal studies, presented at the annual american Chemical Society conference in March, suggest the experiment­al pill is 99 per cent effective, researcher­s claim.

Code-named YCr529, it blocks the effects of a protein — retinoic acid receptor alpha — that plays a crucial role in sperm formation. The drug stops it from binding to sperm cells properly, preventing their growth.

When mice were given the pill daily for four weeks, it dramatical­ly reduced sperm counts and was 99 per cent effective in preventing pregnancy — with no noticeable side-effects. Four to six weeks after the drug was stopped, the male mice were able to father offspring again.

researcher­s said they plan human clinical trials by the end of 2022. But it could still be five years before it is routinely available.

TUBE-BLOCKING GEL THAT’S REVERSIBLE

SCIENTISTS at harbin Medical University in China are working on a radical form of male contracept­ion that involves blocking the passage of sperm from the testes by injecting the vas deferens — the tube that carries sperm out of the body — with a gel that sets firm in under three minutes.

When a couple decide they might want children, the gel can be dissolved in minutes by beaming sound waves through the skin with a hand-held ultrasound device — clearing the way for sperm to leave the body.

In a report in March in the journal aCS Nano, the scientists described how they made the experiment­al gel from water and sodium alginate — a substance found in seaweed.

Once injected, it hardens and blocks a man’s tubes. But it is easily reversed by firing ultrasound at it, turning it into a harmless liquid that gets absorbed by surroundin­g tissue. The seaweed-based gel has only been tested on animals, but in their report the researcher­s said: ‘This could be a reliable, safe and reversible male contracept­ive strategy.’

AFTER-DINNER PILL TO CURB FERTILITY

A ONCE-A-DAY pill that’s taken straight after dinner could give men an effective contracept­ive that lowers testostero­ne levels without significan­t side-effects.

The pill, called dimethandr­olone undecanoat­e (DMaU), is taken after the main meal of the day, as food significan­tly increases the amount that gets absorbed into the bloodstrea­m.

rather than target testostero­ne directly, it suppresses two other hormones — follicle-stimulatin­g hormone and luteinisin­g hormone. Both are important for the production of healthy levels of sperm.

Blocking their production reduces sperm levels enough that conception is extremely unlikely.

Since it doesn’t directly target testostero­ne, it’s hoped the drug will be largely side-effect free.

early trials have suggested it is safe — now a study, involving 84 men, is under way at the University of Washington, which is also investigat­ing whether the drug could be given as a single jab that might act as a contracept­ive for up to six months.

COULD HEAT BE THE ANSWER?

IT’S known that sperm count is reduced by high temperatur­es, and scientists at Nantong University in China are using that effect to develop an unusual form of contracept­ion.

It involves injecting tiny iron nanopartic­les into a vein in the arm or thigh — and then moving a hand-held magnet over the body to guide the particles into the testicles, while monitoring their progress via X-ray.

Once in position, the particles are exposed to a magnetic field — where an electric current is run through a wire — that heats them to 104f, enough to temporaril­y shrink the testicles and reduce sperm production. In tests, a single session stopped mice fathering offspring for a month, according to a July 2021 report in the journal aCS Nano Letters.

 ?? ?? Picture: ALAMY
Picture: ALAMY

Newspapers in English

Newspapers from United Kingdom